Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
Brought to you by

Celgene and Agios enter new deal focused on metabolic immuno-oncology

Executive Summary

Building on a successful relationship that began in 2010, Celgene Corp. and Agios Pharmaceuticals Inc. entered into a new collaboration, this time focused on metabolic immuno-oncology, which involves altering the metabolic state of immune cells to enhance immune response to cancer.

Deal Industry
  • Pharmaceuticals
  • Biotechnology
    • Immuno-Oncology
Deal Status
  • Final
Deal Type
  • Alliance
    • Co-Promotion
    • Includes Royalty or Profit Split Information
    • Intra-Biotech Deal
    • R&D and Marketing (Licensing)

Related Companies

UsernamePublicRestriction

Register